These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder. Houthoofd SA; Morrens M; Sabbe BG Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365 [TBL] [Abstract][Full Text] [Related]
26. Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder. Lindenmayer JP; Khan A; Eerdekens M; Van Hove I; Kushner S Eur Neuropsychopharmacol; 2007 Jan; 17(2):138-44. PubMed ID: 17049818 [TBL] [Abstract][Full Text] [Related]
27. Clinical experience with quetiapine in elderly patients with psychotic disorders. Madhusoodanan S; Brenner R; Alcantra A J Geriatr Psychiatry Neurol; 2000; 13(1):28-32. PubMed ID: 10753004 [TBL] [Abstract][Full Text] [Related]
28. Risperidone for the treatment of behavioral and psychological symptoms of dementia. Tune LE J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986 [TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics. Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593 [TBL] [Abstract][Full Text] [Related]
30. Antipsychotic medication and the elderly. Raskin DE J Clin Psychiatry; 1985 May; 46(5 Pt 2):36-40. PubMed ID: 2859280 [TBL] [Abstract][Full Text] [Related]
32. Risperidone: a review of its use in the management of the behavioural and psychological symptoms of dementia. Bhana N; Spencer CM Drugs Aging; 2000 Jun; 16(6):451-71. PubMed ID: 10939309 [TBL] [Abstract][Full Text] [Related]
34. Domperidone-induced tardive dyskinesia and withdrawal psychosis in an elderly woman with dementia. Roy-Desruisseaux J; Landry J; Bocti C; Tessier D; Hottin P; Trudel JF Ann Pharmacother; 2011 Sep; 45(9):e51. PubMed ID: 21852591 [TBL] [Abstract][Full Text] [Related]
35. Risperidone in the management of psychiatric and neurodegenerative disease in the elderly: an update. DeVane CL; Mintzer J Psychopharmacol Bull; 2003; 37(4):116-32. PubMed ID: 15131522 [TBL] [Abstract][Full Text] [Related]
36. Long-term response to carbamazepine: a retrospective study. Frankenburg FR; Tohen M; Cohen BM; Lipinski JF J Clin Psychopharmacol; 1988 Apr; 8(2):130-2. PubMed ID: 3372707 [TBL] [Abstract][Full Text] [Related]
37. [Late dyskinesia caused by neuroleptics. Survey on 1,660 psychiatric hospital patients]. Bourgeois M; Graux C; Arrethche-Berthelot N Ann Med Psychol (Paris); 1976 May; 1(5):737-46. PubMed ID: 970829 [TBL] [Abstract][Full Text] [Related]
38. Risperidone: treatment response in adult and geriatric patients. Kiraly SJ; Gibson RE; Ancill RJ; Holliday SG Int J Psychiatry Med; 1998; 28(2):255-63. PubMed ID: 9724893 [TBL] [Abstract][Full Text] [Related]
39. Does risperidone have a place in the treatment of nonschizophrenic patients? Schweitzer I Int Clin Psychopharmacol; 2001 Jan; 16(1):1-19. PubMed ID: 11195255 [TBL] [Abstract][Full Text] [Related]
40. [Hydergine in the treatment of chronic psychoses]. Bohard F; Guennoc A; Klein H; Le Borgne Y; Masanes P Ann Med Psychol (Paris); 1967 Mar; 125(3):438-46. PubMed ID: 4964710 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]